title: Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging.
abstract: Negative ion desorption electrospray ionization (DESI) was used for the analysis of an ex vivo tissue sample set comprising primary colorectal adenocarcinoma samples and colorectal adenocarcinoma liver metastasis samples. Frozen sections (12 μm thick) were analyzed by means of DESI imaging mass spectrometry (IMS) with spatial resolution of 100 μm using a computer-controlled DESI imaging stage mounted on a high resolution Orbitrap mass spectrometer. DESI-IMS data were found to predominantly feature complex lipids, including phosphatidyl-inositols, phophatidyl-ethanolamines, phosphatidyl-serines, phosphatidyl-ethanolamine plasmalogens, phosphatidic acids, phosphatidyl-glycerols, ceramides, sphingolipids, and sulfatides among others. Molecular constituents were identified based on their exact mass and MS/MS fragmentation spectra. An identified set of molecules was found to be in good agreement with previously reported DESI imaging data. Different histological tissue types were found to yield characteristic mass spectrometric data in each individual section. Histological features were identified by comparison to hematoxylin-eosin stained neighboring sections. Ions specific to certain histological tissue types (connective tissue, smooth muscle, healthy mucosa, healthy liver parenchyma, and adenocarcinoma) were identified by semi-automated screening of data. While each section featured a number of tissue-specific species, no potential global biomarker was found in the full sample set for any of the tissue types. As an alternative approach, data were analyzed by principal component analysis (PCA) and linear discriminant analysis (LDA) which resulted in efficient separation of data points based on their histological types. A pixel-by-pixel tissue identification method was developed, featuring the PCA/LDA analysis of authentic data set, and localization of unknowns in the resulting 60D, histologically assigned LDA space. Novel approach was found to yield results which are in 95% agreement with the results of classical histology. KRAS mutation status was determined for each sample by standard molecular biology methods and a similar PCA/LDA approach was developed to assess the feasibility of the determination of this important parameter using solely DESI imaging data. Results showed that the mutant and wild-type samples fully separated. DESI-MS and molecular biology results were in agreement in 90% of the cases.
authors.affiliation: Institute for Inorganic and Analytical Chemistry, Justus-Liebig-University, Giessen, Germany.
authors.forename: Stefanie
authors.initials: S
authors.lastname: Gerbig
authors.forename: Ottmar
authors.initials: O
authors.lastname: Golf
authors.forename: Julia
authors.initials: J
authors.lastname: Balog
authors.forename: Julia
authors.initials: J
authors.lastname: Denes
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Baranyai
authors.forename: Attila
authors.initials: A
authors.lastname: Zarand
authors.forename: Erzsebet
authors.initials: E
authors.lastname: Raso
authors.forename: Jozsef
authors.initials: J
authors.lastname: Timar
authors.forename: Zoltan
authors.initials: Z
authors.lastname: Takats
mesh_terms: D000230:Adenocarcinoma / Q000737:chemistry / Q000235:genetics / Q000473:pathology*; D003106:Colon / Q000737:chemistry / Q000378:metabolism / Q000473:pathology*; D015179:Colorectal Neoplasms / Q000737:chemistry / Q000235:genetics / Q000473:pathology*; D006801:Humans; D008099:Liver / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D008113:Liver Neoplasms / Q000235:genetics / Q000556:secondary*; D009154:Mutation; D010743:Phospholipids / Q000032:analysis; D025341:Principal Component Analysis; D011518:Proto-Oncogene Proteins / Q000235:genetics; D016283:Proto-Oncogene Proteins p21(ras); D012007:Rectum / Q000737:chemistry / Q000378:metabolism / Q000473:pathology*; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*; D018631:ras Proteins / Q000235:genetics
chemical_list: C117307:KRAS protein, human; D010743:Phospholipids; D011518:Proto-Oncogene Proteins; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins